Table 2. Dialysis treatment and laboratory characteristics at the initiation of twice-weekly hemodialysis.
| Patient | IDWG* (kg) |
Serum K (mmol/L) |
Phos (mg/dl) |
PTH (pg/ml) |
Hb (mg/dl) |
ESA* (units) |
Serum bicarbonate (mmol/L) |
BMI | PreHD SBP (mmHg) |
HD treatment time (min) |
Dialysate K (meq) |
Vascular access type |
Calcitriol dose (mcg)** |
Serum albumin (mg/dl) |
Serum creatinine (mg/dl) |
Ca (mg/dl) |
Tsat (%) |
Ferritin (ng/ml) |
Na (mmol/L) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient 1 | 1.3 | 3.7 | 3.7 | 7 | 8.4 | 2200 | 23 | 33.1 | 151 | 180 | 3 | TC | 0.25 qd | 3.1 | 3.4 | 9.9 | 16 | 430 | 124 |
| Patient 2 | 1.4 | 4.4 | 7.9 | 92 | 8.8 | 2200 | 17 | 37.0 | 190 | 120 | 3 | AVF | none | 2.8 | 8.5 | 8.3 | 18 | 65 | 140 |
| Patient 3 | 2.0 | 4.7 | 5.7 | 272 | 9.7 | 0 | 18 | 27.1 | 167 | 210 | 2 | TC | none | 3.0 | 4.1 | 8.4 | 38 | 552 | 137 |
| Patient 4 | 1.0 | 4.6 | 3.9 | 244 | 8.8 | 2200 | 27 | 27.6 | 166 | 180 | 3 | TC | none | 2.9 | 6.4 | 9.2 | 30 | 204 | 134 |
| Patient 5 | 0.4 | 7.1 | 4.5 | 895 | 7.3 | 4400 | 19 | 19.9 | 147 | 180 | 1 | AVF | 0.25/HD | 3.8 | 5.4 | 8.8 | 13 | 916 | 138 |
| Patient 6 | 0.2 | 4.4 | 6.9 | 3475 | 8.1 | 2000 | 22 | 22.6 | 135 | 150 | 3 | TC | 0.25/HD | 3.7 | 7.8 | 8.3 | 17 | 322 | 137 |
| Patient 7 | 1.5 | 4.3 | 5.1 | 156 | 8.7 | 3000 | 16 | 23.5 | 155 | 180 | 3 | AVF | 0.25/HD | 3.8 | 10.7 | 8.4 | 14 | 697 | 136 |
| Patient 8 | 1.7 | 4.4 | 6.5 | 990 | 8.8 | 2000 | 16 | 23.7 | 140 | 180 | 2 | TC | 0.25/HD | 3.6 | 6.5 | 7.5 | 35 | 181 | 136 |
| Patient 9 | 1.6 | 4.4 | 7.5 | 311 | 9.3 | 4400 | 25 | 33.2 | 179 | 120 | 3 | AVF | 0.25 qd | 3.9 | 8.0 | 8.2 | 22 | 306 | 138 |
| Patient 10 | 0.3 | 3.3 | 7.3 | 71 | 10.2 | 0 | 23 | 24.8 | 138 | 120 | 3 | AVF | none | 3.4 | 6.3 | 8.7 | 12 | 46 | 140 |
| Patient 11 | 1.2 | 3.0 | 3.8 | 779 | 9.9 | 0 | 18 | 18.4 | 113 | 180 | 3 | TC | 0.25/HD | 2.5 | 7.4 | 6.1 | 57 | 72 | 139 |
| Patient 12 | 1.5 | 4.2 | 7.4 | 339 | 11.6 | 0 | 10 | 35.0 | 149 | 120 | 3 | AVF | 0.5 qd | 4.3 | 8.3 | 8.3 | 20 | 145 | 138 |
| Patient 13 | 0.1 | 3.5 | 5.7 | 1125 | 8.6 | 5000 | 24 | 29.9 | 174 | 210 | 3 | TC | none | 3.5 | 5.8 | 8.8 | 21 | 594 | 135 |
Abbreviations: K: serum potassium; Phos: serum phosphorus; HTN: hypertension; PTH; parathyroid hormone; Hg: hemoglobin; ESA: erythropoietin stimulating agent; BMI: body mass index; HD: hemodialysis; IDWG: interdialytic weight gain; Ca: serum calcium; Tsat: transferrin saturation; Na: serum sodium; TC: tunneled catheter; qd: daily.
*
Equivalent ESA dose among patients receiving varying ESA formulations.
**
Equivalent calcitriol dose among patients receiving varying activated vitamin D/vitamin D analog formulations.